Atara Biotherapeutics: Q1 Earnings Snapshot

Published: 2026-05-12 16:41:13 ET ATRA

Published on 05/12/2026 at 04:41 pm EDT

THOUSAND OAKS, Calif. (AP) — THOUSAND OAKS, Calif. (AP) — Atara Biotherapeutics Inc. (ATRA) on Tuesday reported a first-quarter loss of $4.1 million, after reporting a profit in the same period a year earlier.

The Thousand Oaks, California-based company said it had a loss of 29 cents per share.

The drug developer posted revenue of $516,000 in the period.

Atara Biotherapeutics shares have declined 46% since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $9.81, a climb of 52% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ATRA at https://www.zacks.com/ap/ATRA

For copyright information, check with the distributor of this item, STATS Perform dba Automated Insights. , source Associated Press News